Posaconazole for the treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis

OBJECTIVES: Allergic bronchopulmonary aspergillosis (ABPA) can accelerate lung function decline in patients with cystic fibrosis (CF). Antifungal medication can be used in addition to systemic corticosteroid treatment. PATIENTS AND METHODS: We evaluated Aspergillus-specific IgE and the use of therap...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Antimicrob Chemother
मुख्य लेखकों: Periselneris, J, Nwankwo, L, Schelenz, S, Shah, A, Armstrong-James, D
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Oxford University Press 2019
विषय:
Original Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6664389/
https://ncbi.nlm.nih.gov/pubmed/30805605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkz075
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन